ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2021 American Transplant Congress

    Implementation of an Alcohol Screening Program Identifies Active Pre-transplant Drinking and Allows Engagement in Chemical Dependency Treatment

    N. Lim1, T. Leventhal1, M. Thomson1, M. Hassan1, J. Thompson1, S. Chinnakotla2, V. Kirchner2, T. Pruett2, R. Kandaswamy2, V. Humphreville2, A. Adams2, J. Lake1

    1Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, 2Division of Transplantation, University of Minnesota, Minneapolis, MN

    *Purpose: Alcohol (ETOH) is an important cause of cirrhosis in the US today. Screening patients for ETOH use prior to LT is important to identify…
  • 2021 American Transplant Congress

    Is Low Systemic Fibrinolytic Activity During the Anhepatic Phase Liver Transplant Surgery Associate with the Dreaded Post-Operative Complication of Hepatic Artery Thrombosis?

    H. B. Moore1, Y. Bababekov1, J. Pomposelli1, T. Ferrell1, F. Azam1, M. Adams2, D. Yoeli1, R. Choudhury1, M. Wachs2, E. Pomfret1, T. Nydam1

    1University of Colorado, Aurora, CO, 2Childrens Hospital Colorado, Aurora, CO

    *Purpose: Removal of the native liver during transplantation results in impaired clearance of clot degrading proteins and activation of fibrinolysis as appreciated by Starzl in…
  • 2021 American Transplant Congress

    Liver Transplant Outcomes Using Nationally Allocated Grafts

    S. Ohara1, B. Lizaola-Mayo2, P. Morgan2, D. Das3, J. Wagler4, K. S. Reddy2, B. Aqel2, A. Moss2, C. Jadlowiec2

    1Valleywise Health General Surgery Residency Program, Phoenix, AZ, 2Mayo Clinic, Phoenix, AZ, 3Mayo Clinic Alix School of Medicine, Scottsdale, AZ, 4John C Lincoln, Phoenix, AZ

    *Purpose: There is national variation in acceptance criteria and utilization of livers across transplant centers. Data pertaining to outcomes of liver grafts declined by local…
  • 2021 American Transplant Congress

    Artificial Neural Network Application for MELDNa Prediction

    L. Pruinelli1, M. Nguyen1, S. Olson1, J. Zhou1, J. Schold2, T. Pruett1, S. Ma1, G. Simon1

    1University of Minnesota, Minneapolis, MN, 2Cleveland Clinic Foundation, Cleveland, OH

    *Purpose: The adoption of MELDNa decreased 90-days mortality on patients waiting for liver transplant (LT); however, there are no tools available to predict MELDNa trajectories…
  • 2020 American Transplant Congress

    Liver Transplant Waitlist Mortality is Not Associated with Urbanicity

    Y. Chen1, Y. Hung2, Y. Hsu3, C. de Crescenzo1, C. Rickert1, J. Adler4, D. Chang1, H. Yeh1

    1Surgery, Massachusetts General Hospital, Boston, MA, 2Surgery, Sinai Hospital of Baltimore, Baltimore, MA, 3Harvard School of Public Health, Boston, MA, 4Surgery, Brigham and Women's Hospital, Boston, MA

    *Purpose: Because of geographic disparity in transplant rates and organ usage, distance-based liver distribution has been proposed to replace Donor Service Area based distribution. However,…
  • 2020 American Transplant Congress

    Waitlist Mortality and Transplant Probability for Inactively Listed Liver Patients Depends on Donor Service Areas’ Median MELD at Transplant

    R. Batra1, S. Noreen2, D. Stewart2, D. Haakinson1, G. Gan3, Y. Deng3, S. Kulkarni1

    1Surgery, Yale University School of Medicine, New Haven, CT, 2UNOS, Richmond, VA, 3Yale University, New Haven, CT

    *Purpose: Presently, the outcome of patients listed inactive on liver transplant waiting list (WL) are unknown; as inactive patients cannot receive deceased donor organ offers,…
  • 2020 American Transplant Congress

    Early Recurrence Of Hepatocellular Carcinoma Following Transplantation: Risk Score From A Multi-institutional Study Of > 3000 Patients

    P. Tabrizian1, M. Holzner2, V. Agopian3, R. Busuttil3, G. Sapisochin4, N. Mehta5, F. Yao5, J. Roberts6, S. Florman1, M. E. Schwartz1, T. Ivanics7, J. Emond8, B. Samstein9, R. Brown, MD, MPH9, M. Najjar10, W. Chapman11, M. Doyle11, K. Halazun9

    1Transplant, Mount Sinai Medical Center, New York, NY, 2Surgery, Georgetown University Hospital, Washington DC, MD, 3Transplant, David Geffen School of Medicine at UCLA, Los Angeles, CA, 4Transplant, Univeristy of Toronto, Toronto, ON, Canada, 5Transplant, UCSF, San Francisco, CA, 6Transplantation, UCSF, San Francisco, CA, 7Transplant, University of Toronto, Toronto, ON, Canada, 8Transplant, Columbia University Medical Center, New York, NY, 9Transplant, Weill Cornell Medical Center, New York, NY, 10Transplant, Columbia Medical Center, New York, NY, 11Transplant, Washington University School of Medicine, St Louis, MO

    *Purpose: Early recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) carries a poor prognosis. We aimed to develop a risk score for early HCC…
  • 2020 American Transplant Congress

    Higher Probability of Living Donor Liver Transplantation is Associated with DSAs Having a Higher Median Meld at Transplant

    D. Haakinson1, S. Noreen2, D. Stewart2, R. Batra1, G. Gan1, Y. Deng1, S. Kulkarni1

    1Yale, New Haven, CT, 2UNOS, Richmond, VA

    *Purpose: Recent studies show that outcomes of living donor liver transplantation (LDLT) are superior compared to those receiving deceased donor grafts. Access to deceased donor…
  • 2020 American Transplant Congress

    Human Antigen R (HuR): A New Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplantation

    K. J. Dery1, K. Nakamura2, K. Kadono1, H. Hirao1, S. Kageyama1, T. Ito1, H. Kojima1, F. Kaldas1, R. W. Busuttil1, J. W. Kupiec-Weglinski1

    1Department of Surgery, Division of Liver and Pancreas Transplantation, UCLA, Los Angeles, CA, 2Surgery, Nishi-Kobe Medical Center, Hyogo, Japan

    *Purpose: Ischemia-reperfusion injury (IRI) represents a risk factor in liver transplantation (LT). We have shown that overexpression of heme oxygenase 1 (HO-1) mitigates hepatic IRI…
  • 2020 American Transplant Congress

    Management of Hepatic Artery Stenosis Post Liver Transplant

    S. Bommena, I. Joshi, P. Kang, T. Chaly, A. Seetharam, N. Patel, M. B. Fallon, S. Mehta

    Banner University Medical Center, University of Arizona College of Medicine, Phoenix, AZ

    *Purpose: Hepatic Artery Stenosis (HAS) is a significant complication after liver transplantation associated with morbidity. The primary aim of this study is to determine if…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences